[ORGANIZATION]
Ann & Robert H. Lurie Children's Hospital of Chicago
Featured in 3 tracked stories · first seen
Situations
GLP-1 drugs: clinical trends, safety, and market shifts
291 clusters · 1104 sources · last updated
Latest: Novo Nordisk faces lawsuits over Ozempic and NAION risks
Since mid-2026, the expansion of GLP-1 agents for obesity has been accompanied by intensified safety monitoring and evolving clinical data. Research suggests secondary benefits, including a 21% lower risk of fragility fr
Also covered in
-
Medical updates: FDA designations and pediatric mental health trends
[HEALTH] · 3 sources ·